Trailing-twelve-month (TTM) revenue is $159.27 Million with a year-over-year growth of +2.02%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $38,441,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $44,645,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-03-31 | $37,178,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $39,007,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $159,271,000 |
Current P/S: $838,624,558 market capitalization ÷ $159,271,000 TTM revenue = 5.27x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:35:17.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $39.01M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:38:37.114Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Consumable | $33M | $31M | $52M | $60M | $70M | $82M |
| Instrument | $45M | $34M | $61M | $49M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | N/A | N/A | N/A | N/A | $79M | $73M |
| Asia Pacific | $27M | $23M | $36M |
$159.27M
$159.27 Million
+2.02%
vs. $156.12M a year ago (TTM)
+8.52%
5 Year compound annual growth rate
1 Year
+2.02%
3 Year
(2.24%)
5 Year
+8.52%
10 Year
+5.87%
15 Year
+19.22%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $160.00M | +$5.99M | +3.89% |
| 2024 | $154.01M | ($46.51M) | (23.19%) |
| 2023 | $200.52M | +$72.22M | +56.29% |
| 2022 | $128.30M | ($2.21M) | (1.69%) |
| 2021 | $130.51M | +$51.62M | +65.43% |
| 2020 |
TTM Growth
+2.02%
3-Year CAGR
(2.24%)
5-Year CAGR
+8.52%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:38:37.114Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $66M |
| $54M |
| Product | $78M | $65M | $114M | $109M | $136M | $136M |
|---|
| Service And Other | $13M | $13M | $17M | $20M | $18M | $24M |
|---|
| $41M |
| $43M |
| EMEA | N/A | N/A | N/A | N/A | $35M | $44M |
|---|
| Europe | $20M | $19M | $30M | $23M | N/A | N/A |
|---|
| North America | $45M | $37M | $65M | $70M | N/A | N/A |
|---|
| UNITED STATES | N/A | N/A | N/A | N/A | $75M | $70M |
|---|
| $78.89M |
| ($12.00M) |
| (13.20%) |
| 2019 | $90.89M | +$12.27M | +15.60% |
| 2018 | $78.63M | ($14.84M) | (15.88%) |
| 2017 | $93.47M | +$2.75M | +3.04% |
| 2016 | $90.71M | ($2.07M) | (2.23%) |
